Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteries | 4 | 2009 | 81 | 1.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 167 | 0.640 |
Why?
|
| Blood Pressure | 5 | 2014 | 666 | 0.520 |
Why?
|
| Menarche | 1 | 2015 | 15 | 0.450 |
Why?
|
| Cardiovascular Diseases | 4 | 2009 | 749 | 0.410 |
Why?
|
| Tunica Media | 3 | 2008 | 15 | 0.400 |
Why?
|
| Vascular Resistance | 3 | 2009 | 36 | 0.380 |
Why?
|
| Age Factors | 2 | 2015 | 1154 | 0.370 |
Why?
|
| Premature Birth | 2 | 2011 | 95 | 0.370 |
Why?
|
| Tunica Intima | 2 | 2008 | 22 | 0.340 |
Why?
|
| Infant, Low Birth Weight | 2 | 2011 | 36 | 0.330 |
Why?
|
| Fetal Organ Maturity | 1 | 2010 | 3 | 0.330 |
Why?
|
| Adult | 16 | 2025 | 13872 | 0.310 |
Why?
|
| Louisiana | 5 | 2010 | 50 | 0.300 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2008 | 12 | 0.280 |
Why?
|
| Bilirubin | 1 | 2008 | 18 | 0.280 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 26 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 75 | 0.280 |
Why?
|
| Angiotensinogen | 1 | 2007 | 6 | 0.270 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 9 | 0.270 |
Why?
|
| Risk Factors | 10 | 2025 | 3994 | 0.270 |
Why?
|
| Female | 19 | 2025 | 24698 | 0.260 |
Why?
|
| HIV Infections | 5 | 2025 | 2586 | 0.250 |
Why?
|
| Pulsatile Flow | 1 | 2006 | 28 | 0.240 |
Why?
|
| Radial Artery | 2 | 2020 | 3 | 0.240 |
Why?
|
| Young Adult | 6 | 2025 | 5080 | 0.230 |
Why?
|
| Humans | 21 | 2025 | 43102 | 0.230 |
Why?
|
| Femoral Artery | 2 | 2020 | 12 | 0.220 |
Why?
|
| Compliance | 3 | 2009 | 14 | 0.210 |
Why?
|
| Male | 14 | 2025 | 23409 | 0.200 |
Why?
|
| Depression | 2 | 2021 | 863 | 0.200 |
Why?
|
| Cholesterol, HDL | 2 | 2021 | 99 | 0.200 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1063 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 863 | 0.190 |
Why?
|
| Adolescent | 5 | 2025 | 6081 | 0.190 |
Why?
|
| Carotid Arteries | 2 | 2015 | 36 | 0.180 |
Why?
|
| Quarantine | 1 | 2021 | 7 | 0.170 |
Why?
|
| Mass Screening | 1 | 2025 | 541 | 0.170 |
Why?
|
| Sexual Behavior | 1 | 2025 | 638 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 706 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2011 | 117 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2011 | 229 | 0.140 |
Why?
|
| Gene Frequency | 2 | 2008 | 206 | 0.130 |
Why?
|
| Competitive Behavior | 1 | 2017 | 15 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 247 | 0.130 |
Why?
|
| Running | 1 | 2017 | 13 | 0.130 |
Why?
|
| Religion and Medicine | 1 | 2017 | 20 | 0.130 |
Why?
|
| Mental Health | 1 | 2021 | 385 | 0.130 |
Why?
|
| Walking | 1 | 2017 | 88 | 0.120 |
Why?
|
| Southeastern United States | 2 | 2025 | 64 | 0.120 |
Why?
|
| Genotype | 2 | 2008 | 800 | 0.110 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2025 | 82 | 0.110 |
Why?
|
| Middle Aged | 8 | 2025 | 12222 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2015 | 78 | 0.110 |
Why?
|
| United States | 2 | 2025 | 5205 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 317 | 0.100 |
Why?
|
| Anxiety | 1 | 2021 | 874 | 0.100 |
Why?
|
| Child | 1 | 2021 | 3443 | 0.090 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 54 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 193 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2011 | 2544 | 0.090 |
Why?
|
| Birth Weight | 1 | 2011 | 95 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 712 | 0.080 |
Why?
|
| New Orleans | 1 | 2010 | 17 | 0.080 |
Why?
|
| Pregnancy | 3 | 2011 | 1772 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2011 | 972 | 0.080 |
Why?
|
| Muscle Tonus | 1 | 2009 | 6 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 110 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2009 | 63 | 0.070 |
Why?
|
| HTLV-II Infections | 1 | 2007 | 6 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 201 | 0.070 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 33 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2009 | 263 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2007 | 135 | 0.060 |
Why?
|
| Lung | 1 | 2010 | 492 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 7 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2008 | 201 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1028 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 211 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2007 | 169 | 0.060 |
Why?
|
| Health | 1 | 2005 | 30 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 367 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2009 | 1759 | 0.060 |
Why?
|
| Mississippi | 2 | 2015 | 129 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 734 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2025 | 326 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2025 | 457 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 1003 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 755 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2005 | 925 | 0.040 |
Why?
|
| Hypertension | 1 | 2007 | 835 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2020 | 55 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3156 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 8214 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1604 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 1857 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 29 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 760 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 175 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 147 | 0.030 |
Why?
|
| Urban Population | 1 | 2015 | 374 | 0.020 |
Why?
|
| Motivation | 1 | 2017 | 513 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 389 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2853 | 0.020 |
Why?
|
| Chorioamnionitis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 97 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 86 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 368 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 518 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 339 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 575 | 0.020 |
Why?
|
| Genes, pX | 1 | 2007 | 3 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2007 | 29 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2007 | 75 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1009 | 0.020 |
Why?
|
| Viral Load | 1 | 2007 | 348 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2007 | 311 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2007 | 1600 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1271 | 0.010 |
Why?
|